Profile data is unavailable for this security.
About the company
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
- Revenue in CHF (TTM)969.46m
- Net income in CHF-117.57m
- Incorporated1993
- Employees1.45k
- LocationDocMorris AGWalzmuehlestrasse 49FRAUENFELD 8500SwitzerlandCHE
- Phone+41 527240020
- Fax+41 527240015
- Websitehttps://www.zurrosegroup.com/
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 06 May 2024 | 2.66m | 17.95% |
| Sands Capital Management LLCas of 31 Dec 2023 | 675.58k | 4.56% |
| Swisscanto Fondsleitung AGas of 21 Jun 2024 | 426.81k | 2.88% |
| LMR Partners LLPas of 31 Dec 2023 | 413.76k | 2.79% |
| Sculptor Capital LPas of 16 Apr 2024 | 409.65k | 2.76% |
| PSquared Asset Management AGas of 31 Dec 2023 | 408.17k | 2.75% |
| Shareholder Value Management AGas of 29 Dec 2023 | 380.00k | 2.56% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 315.42k | 2.13% |
| Credit Suisse Asset Management (Schweiz) AGas of 28 Jun 2024 | 298.50k | 2.01% |
| TFG Asset Management UK LLPas of 08 Jun 2023 | 231.97k | 1.57% |
